Researchers predicted the likelihood of achieving target T-scores in postmenopausal women with osteoporosis who received denosumab therapy for 10 years.

Osteoporosis drug Prolia faces intense competition as patents expire and generics launch Intense rivalry emerges in the ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...

After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml solution, as well as a 120 mg/1.7 ml solution in a single-dose vial.

While increased average life expectancy is a testament to modern medicine and public health efforts, an aging population ...

Background: Osteoporosis is a serious health issue that can lead to severe clinical diseases, involving fractures. The ...

Keep reading for more information on how AS and osteoporosis are connected, treatment options, when to contact a doctor, and more. They also noted earlier development of osteoporosis in people ...